Rolf Classon

Track

Insider profile

Currently holds positions in Catalent Inc, Perrigo Company PLC and Fresenius Medical Care AG & Co KGaA

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 49% 68% 82%
Transactions
10 90% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Catalent Inc Aug. 14, 2014 -
Independent Director Perrigo Company PLC May 2, 2017 -
Independent Vice Chairman of the Supervisory Board Fresenius Medical Care AG & Co KGaA Nov. 30, 2018 -
Independent Member of the Supervisory Board Fresenius Medical Care AG & Co KGaA May 11, 2011 - Nov. 30, 2018
Non-Executive Chairman of the Board Tecan Group AG April 22, 2009 - April 17, 2018
Independent Chairman of the Board Hill-Rom Holdings Inc March 20, 2006 - March 6, 2018
Independent Chairman of the Board Auxilium Pharmaceuticals LLC April 1, 2005 - Jan. 29, 2015
Independent Director Medivir AB May 10, 2012 - May 8, 2014
Director Hill-Rom Holdings Inc May 16, 2002 - Dec. 4, 2003
Rolf Classon's trades of Fresenius Medical Care AG's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
136.29
Quantity 58,791
Value US$1,262,814
Transaction date
Purchase
Price
396.12
Quantity 89,138 +3.8%
Value US$4,567,536
Transaction date
Purchase
Price
155.01
Quantity 65,202 -24.5%
Value US$3,231,691
Transaction date
Purchase
Price
4.07
Quantity 5,500 +52.6%
Value US$22,385
Transaction date
Purchase
Price
4.06
Quantity 1,600 +18.1%
Value US$6,496
Transaction date
Purchase
Price
4.05
Quantity 300 +3.5%
Value US$1,215
Transaction date
Purchase
Price
4.04
Quantity 500 +6.2%
Value US$2,020
Transaction date
Purchase
Price
4.03
Quantity 400 +5.2%
Value US$1,612
Transaction date
Purchase
Price
4.02
Quantity 700 +10.1%
Value US$2,814
Transaction date
Purchase
Price
4.01
Quantity 1,000 +16.8%
Value US$4,010
Transaction date
Sale
Price
8.23
Quantity 30,000 -70.6%
Value US$246,810
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-20 2023-12-20
PrS Proposed sale
58,791
136.29
US$1,262,814 		58,791 136.29 US$1,262,814
2021-12-03 2021-12-02
B Purchase
89,138 +3.8%
396.12
US$4,567,536 		89,138 +3.8% 396.12 US$4,567,536
2020-11-10 2020-11-09
B Purchase
65,202 -24.5%
155.01
US$3,231,691 		65,202 -24.5% 155.01 US$3,231,691
2008-11-18 2008-11-17
B Purchase
5,500 +52.6%
4.07
US$22,385 		5,500 +52.6% 4.07 US$22,385
2008-11-18 2008-11-17
B Purchase
1,600 +18.1%
4.06
US$6,496 		1,600 +18.1% 4.06 US$6,496
2008-11-18 2008-11-17
B Purchase
300 +3.5%
4.05
US$1,215 		300 +3.5% 4.05 US$1,215
2008-11-18 2008-11-17
B Purchase
500 +6.2%
4.04
US$2,020 		500 +6.2% 4.04 US$2,020
2008-11-18 2008-11-17
B Purchase
400 +5.2%
4.03
US$1,612 		400 +5.2% 4.03 US$1,612
2008-11-18 2008-11-17
B Purchase
700 +10.1%
4.02
US$2,814 		700 +10.1% 4.02 US$2,814
2008-11-18 2008-11-17
B Purchase
1,000 +16.8%
4.01
US$4,010 		1,000 +16.8% 4.01 US$4,010
2006-12-13 2006-12-11
S Sale
30,000 -70.6%
8.23
US$246,810 		30,000 -70.6% 8.23 US$246,810